(Q43983874)

reason for preferred rank

28 November 2017

Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight–week randomized, double-blind trial (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

1 reference

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

author name string

van de Putte LB

3

1 reference

28 November 2017

M. E. Jeurissen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

A. M. Boerbooms

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

L. B. van de Putte

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

W. H. Doesburg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

J. Mulder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

J. J. Rasker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

M. W. Kruijsen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

J. F. Haverman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

H. J. van Beusekom

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

W. H. Muller

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1859490

11 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1859490

11 December 2022

publication date

1 August 1991

1 reference

full work available at URL

28 November 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780340805

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780340805

11 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

published in

Arthritis & Rheumatology

1 reference

28 November 2017

Arthritis and Rheumatism

34

8

961–72

August 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1859490

11 December 2022

volume

34

1 reference

28 November 2017

8

1 reference

28 November 2017

961-972

1 reference

Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FART.1780340805

Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FART.1780340805

21 January 2018

2

16

575

Wilske

1989

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

3

16

1175

Hess

1989

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Methotrexate and rheumatoid arthritis

11 December 2022

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Methotrexate in refractory rheumatoid arthritis

11 December 2022

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis.

11 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine

11 December 2022

7

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial

11 December 2022

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold

11 December 2022

10

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

Danish medical bulletin

11

31

403

Halberg

1984

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

12

15

753

Suarez-Almazor

1988

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

13

16

302

Morassut

1989

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

14

11

760

Thompson

1984

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Efficacy of low-dose methotrexate in rheumatoid arthritis

11 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

11 December 2022

17

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

11 December 2022

18

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months

11 December 2022

19

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations

11 December 2022

20

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression

11 December 2022

21

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial

11 December 2022

22

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Bulletin on the rheumatic diseases

11 December 2022

24

9

175

Ropes

1958

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

11 December 2022

25

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Therapeutic criteria in rheumatoid arthritis

11 December 2022

26

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Prediction of creatinine clearance from serum creatinine

11 December 2022

27

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

The Quarterly Journal of Medicine

11 December 2022

28

37

393

Ritchie

1968

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Disease activity and joint damage progression in early rheumatoid arthritis: relation to IgG, IgA, and IgM rheumatoid factor

11 December 2022

29

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Clinical significance of calcium salts in synovial fluid

11 December 2022

30

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine induced fever, chills, rash, and hepatotoxicity in rheumatoid arthritis

11 December 2022

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

32

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis

11 December 2022

33

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine in rheumatoid arthritis. A double-blind, cross over study

11 December 2022

35

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine in rheumatoid arthritis: double-blind study of full versus half doses versus placebo

11 December 2022

36

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

37

1

274

Urowitz

1974

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment

11 December 2022

38

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

39

12

35

Weinblatt

1985

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

40

14

74

Gispen

1987

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

41

55

161

Bunch

1980

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Rheumatoid arthritis: treatment with azathioprine (IMURAN (R)). Clinical side-effects and laboratory abnormalities

11 December 2022

42

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Histocompatibility antigens in systemic-onset juvenile rheumatoid arthritis

11 December 2022

43

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

Azathioprine hypersensitivity. Case report and review of the literature

11 December 2022

44

1 reference

https://api.crossref.org/works/10.1002/ART.1780340805

11 December 2022

Identifiers

1 reference

28 November 2017

1 reference